DailySpaceUMediC Group Berhad
0256 · Main Market主板（Main Market） · annual reports 2023 to 2025, 1423 entries read2023 至 2025 年报，共读出 1423 条
The company这家公司
UMediC markets and distributes medical devices and consumables and manufactures its own medical consumables. Its products include HYDROX prefilled humidifiers, HYDROX prefilled nebulizers, AIRDROX inhaler spacers and FLEXIDROX water for inhalation bags. It has also added healthcare, ambulance and training services.UMediC 营销及分销医疗器械与耗材，也制造自有医疗耗材。产品包括 HYDROX 预充式湿化瓶、HYDROX 预充式雾化器、AIRDROX 吸入辅助器及 FLEXIDROX 吸入用水袋。集团也增加了医疗护理、救护车及培训服务。
Source: annual report 2023, page 127; annual report 2025, pages 13, 15.出处：2023 年年报第 127 页；2025 年年报第 13、15 页。
In 2025, manufacturing brought in RM16.4 million and marketing and distribution RM32.2 million. Malaysia contributed 67.90% of revenue and overseas markets 32.10%. No customer accounted for ten percent or more of group revenue. Nursing services contributed RM11,080.2025 年，制造业务带来 RM16.4 million，营销及分销业务带来 RM32.2 million。马来西亚占营业额 67.90%，海外市场占 32.10%。没有客户占集团营业额的百分之十或以上。护理服务贡献 RM11,080。
Source: annual report 2025, pages 17, 107, 109, 128.出处：2025 年年报第 17、107、109、128 页。
The 2025 largest-shareholders list records NG CHAI ENG (DATO' SERI) with 90,953,419 shares (24.325%), LIM TAW SEONG with 62,424,332 (16.695%) and LAU CHEE KHEONG with 59,036,260 (15.789%). A separate MAYBANK NOMINEES (TEMPATAN) SDN BHD private wealth management account for LAU CHEE KHEONG holds 10,000,000 shares (2.674%). Dato’ Seri Ng Chai Eng is the Non-Independent Non-Executive Chairman, father of his Alternate Director Ng Sze Hui and uncle of Executive Director/Chief Executive Officer Lim Taw Seong.2025 年最大股东名单列出 NG CHAI ENG (DATO' SERI) 持有 90,953,419 股（24.325%）、LIM TAW SEONG 持有 62,424,332 股（16.695%），以及 LAU CHEE KHEONG 持有 59,036,260 股（15.789%）。另一个以 MAYBANK NOMINEES (TEMPATAN) SDN BHD 名义为 LAU CHEE KHEONG 持有的私人财富管理账户有 10,000,000 股（2.674%）。Dato’ Seri Ng Chai Eng 是非独立非执行主席，是其替任董事 Ng Sze Hui 的父亲，也是执行董事兼首席执行员 Lim Taw Seong 的叔父。
Source: annual report 2025, pages 26, 27, 32, 143.出处：2025 年年报第 26、27、32、143 页。
The 2025 list includes these pledged securities accounts: CGS INTERNATIONAL NOMINEES MALAYSIA (TEMPATAN) SDN. BHD. for MOHAMAD DAUD BIN MOHD YUSOFF, 1,309,800 shares (0.350%); MAYBANK NOMINEES (TEMPATAN) SDN BHD for SYED ABU HUSSIN BIN HAFIZ SYED ABDUL FASAL, 1,462,500 (0.391%); and MAYBANK NOMINEES (TEMPATAN) SDN BHD for SYED ABU SALIM BIN HAFIS SYED ABD FASAL, 1,010,000 (0.270%).2025 年名单列有以下质押证券账户：CGS INTERNATIONAL NOMINEES MALAYSIA (TEMPATAN) SDN. BHD. 为 MOHAMAD DAUD BIN MOHD YUSOFF 持有 1,309,800 股（0.350%）；MAYBANK NOMINEES (TEMPATAN) SDN BHD 为 SYED ABU HUSSIN BIN HAFIZ SYED ABDUL FASAL 持有 1,462,500 股（0.391%）；以及 MAYBANK NOMINEES (TEMPATAN) SDN BHD 为 SYED ABU SALIM BIN HAFIS SYED ABD FASAL 持有 1,010,000 股（0.270%）。
Source: annual report 2025, page 143.出处：2025 年年报第 143 页。
Other pledged securities accounts in that list are MAYBANK SECURITIES NOMINEES (TEMPATAN) SDN BHD for CHAN CHEE WOH, 666,000 shares (0.178%), and for BOB STANDARD SDN. BHD., 699,000 (0.187%); ALLIANCEGROUP NOMINEES (TEMPATAN) SDN BHD for TEOH HUI PENG, 1,100,000 (0.294%); PUBLIC NOMINEES (TEMPATAN) SDN BHD for LEE BOON TIONG, 647,300 (0.173%); and RHB NOMINEES (TEMPATAN) SDN BHD for LEE BOON TIONG, 650,000 (0.174%).该名单的其他质押证券账户包括：MAYBANK SECURITIES NOMINEES (TEMPATAN) SDN BHD 为 CHAN CHEE WOH 持有 666,000 股（0.178%），以及为 BOB STANDARD SDN. BHD. 持有 699,000 股（0.187%）；ALLIANCEGROUP NOMINEES (TEMPATAN) SDN BHD 为 TEOH HUI PENG 持有 1,100,000 股（0.294%）；PUBLIC NOMINEES (TEMPATAN) SDN BHD 为 LEE BOON TIONG 持有 647,300 股（0.173%）；以及 RHB NOMINEES (TEMPATAN) SDN BHD 为 LEE BOON TIONG 持有 650,000 股（0.174%）。
Source: annual report 2025, page 143.出处：2025 年年报第 143 页。
Ng Sze Hui became Alternate Director to Dato’ Ng Chai Eng on 6 March 2023, replacing Dr. Ng Chin Liang. Lau Chee Kheong resigned as Non-Independent Non-Executive Director on 5 October 2023. Dato’ Dr. Teh Keng Hwang was appointed Independent Non-Executive Director on the same date.Ng Sze Hui 于 2023 年 3 月 6 日出任 Dato’ Ng Chai Eng 的替任董事，接替 Dr. Ng Chin Liang。Lau Chee Kheong 于 2023 年 10 月 5 日辞任非独立非执行董事。Dato’ Dr. Teh Keng Hwang 于同日获委任为独立非执行董事。
Source: annual report 2023, pages 3, 37, 86.出处：2023 年年报第 3、37、86 页。
Revenue by segment, 20252025 年各业务营业额
Source: annual report 2025, page 107.出处：2025 年年报第 107 页。
Revenue by market, 20252025 年各市场营业额
Source: annual report 2025, page 109.出处：2025 年年报第 109 页。
Major events大事记
Source: annual report 2023, page 88.出处：2023 年年报第 88 页。
Source: annual report 2023, page 91.出处：2023 年年报第 91 页。
Source: annual report 2023, page 128.出处：2023 年年报第 128 页。
Source: annual report 2024, page 15.出处：2024 年年报第 15 页。
Source: annual report 2024, page 13.出处：2024 年年报第 13 页。
Source: annual report 2024, pages 13, 14.出处：2024 年年报第 13、14 页。
Source: annual report 2025, pages 12, 117.出处：2025 年年报第 12、117 页。
Source: annual report 2025, page 85.出处：2025 年年报第 85 页。
Source: annual report 2025, pages 13, 88.出处：2025 年年报第 13、88 页。
Revenue, profit and operating cash营业额、盈利与营运现金
Cash, short-term funds and borrowings现金、短期基金与借款
20232023 年
Operations generated RM1.8 million in cash. Property, plant and equipment purchases used RM5.3 million. Short-term fund disposals brought in RM35.5 million, while placements used RM25.8 million. The group repaid RM3.0 million of term loans. It paid RM600,000 for a 70% stake in Patho; the acquired company's cash was RM886,775, giving a net acquisition cash inflow of RM286,775. Non-controlling interests contributed RM300,000.营运活动产生 RM1.8 million 现金。购买产业、厂房及设备用了 RM5.3 million。赎回短期基金收回 RM35.5 million，投入短期基金用了 RM25.8 million。集团偿还 RM3.0 million 定期贷款。集团以 RM600,000 收购 Patho 的 70% 股权；被收购公司的现金为 RM886,775，因此收购带来 RM286,775 现金净流入。非控股权益投入 RM300,000。
Source: annual report 2023, pages 105, 106, 128.出处：2023 年年报第 105、106、128 页。
20242024 年
Operations generated RM4.3 million in cash. Property, plant and equipment purchases used RM6.3 million, and term loan repayments used RM2.7 million. Short-term fund disposals brought in RM8.1 million, while purchases used RM5.2 million. Cash and bank balances ended the year at RM4.2 million, with a separate RM9.3 million in short-term funds. The Company issued no new shares during the year.营运活动产生 RM4.3 million 现金。购买产业、厂房及设备用了 RM6.3 million，偿还定期贷款用了 RM2.7 million。赎回短期基金收回 RM8.1 million，购买短期基金用了 RM5.2 million。年末现金与银行结余为 RM4.2 million，另有 RM9.3 million 短期基金。公司年内没有发行新股。
Source: annual report 2024, pages 88, 102.出处：2024 年年报第 88、102 页。
20252025 年
Operations generated RM11.2 million in cash. Property, plant and equipment purchases used RM8.0 million. The group repaid RM861,877 of term loans and ended the year with no borrowings. It paid RM60,000 in dividends to non-controlling interests and received RM374,870 from subsidiaries' share issues to non-controlling interests. Short-term fund disposals brought in RM9.1 million, while purchases used RM4.5 million. Year-end cash and bank balances were RM11.6 million, with RM4.9 million in short-term funds.营运活动产生 RM11.2 million 现金。购买产业、厂房及设备用了 RM8.0 million。集团偿还 RM861,877 定期贷款，年末借款为零。集团向非控股权益支付 RM60,000 股息，并从子公司向非控股权益发行股份收到 RM374,870。赎回短期基金收回 RM9.1 million，购买短期基金用了 RM4.5 million。年末现金与银行结余为 RM11.6 million，短期基金为 RM4.9 million。
Source: annual report 2025, pages 104, 125.出处：2025 年年报第 104、125 页。
Across the years跨年合看
Revenue moved from RM45.4 million to RM54.6 million and then RM48.6 million. Group profit for the financial year moved from RM10.4 million to RM9.3 million and then RM8.3 million. Borrowings fell across the reports, from RM3.6 million to RM861,877 and then nil. The Company did not propose, declare or pay dividends for these financial years. It issued no new shares in the final two years.营业额由 RM45.4 million 升至 RM54.6 million，再降至 RM48.6 million。集团本财政年度盈利由 RM10.4 million 降至 RM9.3 million，再降至 RM8.3 million。各份年报的借款由 RM3.6 million 降至 RM861,877，再降至零。公司在这些财政年度没有建议、宣布或支付股息。最后两个年度没有发行新股。
Source: annual report 2023, page 142; annual report 2024, page 88; annual report 2025, page 88.出处：2023 年年报第 142 页；2024 年年报第 88 页；2025 年年报第 88 页。
Still to be spent尚未支出
At the latest year end, capital commitments contracted but not provided for were RM6.9 million; approved but uncontracted commitments were nil. The report describes RM5.0 million of remaining IPO proceeds. On 5 June 2025, the Company announced changes to their use and an extension to 4 December 2025. The allocation for machinery, systems and cleanroom expansion was 8.49% utilised. The allocation for new marketing and distribution offices was removed.最新年末，已签约但尚未计提的资本承诺为 RM6.9 million；已批准但未签约的承诺为零。年报说明尚余 RM5.0 million 首次公开募股资金。公司于 2025 年 6 月 5 日宣布更改用途，并把使用期限延至 2025 年 12 月 4 日。用于机械、系统及洁净室扩建的拨款已使用 8.49%。新营销及分销办事处的拨款已取消。
Source: annual report 2025, pages 10, 85, 127.出处：2025 年年报第 10、85、127 页。
Four years of figures四年数字
Group figures, in RM, as printed in the statements.集团数字，单位令吉，照财务报表所印。
| Group集团 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| RM令吉 | RM令吉 | RM令吉 | RM令吉 | |
| Revenue营业额 | 50,738,156 | 45,432,437 | 54,570,002 | 48,564,379 |
| Profit before tax税前盈利 | 8,481,667 | 12,931,716 | 12,640,520 | 10,850,769 |
| Profit for the financial year本财政年度盈利 | 6,425,995 | 10,363,623 | 9,296,910 | 8,264,189 |
| Net cash from operating activities营运活动所得现金净额 | 8,478,170 | 1,804,078 | 4,323,754 | 11,184,882 |
| Purchase of property, plant and equipment购买产业、厂房及设备 | (1,011,261) | (5,313,071) | (6,305,673) | (8,041,600) |
| Cash dividends paid to non-controlling interests向非控股权益支付的现金股息 | – | – | 0 | (60,000) |
| Total assets总资产 | 68,890,545 | 73,291,741 | 82,707,981 | 91,224,209 |
| Total borrowings总借款 | 7,996,668 | 3,588,306 | 861,877 | 0 |
| Cash and bank balances现金与银行结余 | 4,159,584 | 6,106,628 | 4,231,579 | 11,616,715 |
| Short term funds短期基金 | 21,007,257 | 11,873,704 | 9,278,269 | 4,949,869 |
| Total equity总权益 | 52,678,647 | 63,476,312 | 72,773,352 | 81,352,411 |
On a computer, hover over a figure for the report and page it is printed on.在电脑上把鼠标移到数字上，可看到它印在哪份年报的哪一页。
Said and done说过的与做到的
| What the reports said年报说要做的 | What later reports show之后年报显示的 | Status状态 |
|---|---|---|
| The 2024 report expected monthly prefilled humidifier capacity to reach 600,000 bottles by December 2024.2024 年报预计，预充式湿化瓶月产能将在 2024 年 12 月达到 600,000 瓶。 | The 2025 report gives monthly capacity of 433,000 bottles, up from 420,000.2025 年报列出的月产能为 433,000 瓶，高于此前的 420,000 瓶。 Source: annual report 2024, page 14; annual report 2025, page 14.出处：2024 年年报第 14 页；2025 年年报第 14 页。 | Reported capacity below target所报产能低于目标 |
| Plant 2 was to be fully operational by the end of 2024.Plant 2 原定于 2024 年底全面运作。 | The later report says Plant 2 was occupied in early 2025. It reports completed cleanroom and packing-room enhancements, but gives no date for full operation.后来的年报表示，Plant 2 于 2025 年初入驻。年报说明洁净室及包装室改善工程已完成，但没有给出全面运作的日期。 Source: annual report 2024, page 14; annual report 2025, page 14.出处：2024 年年报第 14 页；2025 年年报第 14 页。 | Occupied in early 2025; full operation date not stated2025 年初入驻；未说明全面运作日期 |
| The 2023 report planned new marketing and distribution offices with showrooms in Kuala Lumpur and Johor Bahru, with RM6.8 million of IPO proceeds allocated.2023 年报计划在 Kuala Lumpur 及 Johor Bahru 设立附展示厅的新营销及分销办事处，并拨出 RM6.8 million 首次公开募股资金。 | The 2025 report says marketing and distribution offices have been established in Kuala Lumpur and Johor. It still describes offices with dedicated showrooms as planned, and the IPO allocation for new offices was removed.2025 年报表示，集团已在 Kuala Lumpur 及 Johor 设立营销及分销办事处。但附专用展示厅的办事处仍列为计划，新办事处的首次公开募股拨款也已取消。 Source: annual report 2023, page 17; annual report 2025, pages 20, 52, 85.出处：2023 年年报第 17 页；2025 年年报第 20、52、85 页。 | Showroom offices still planned; allocation removed展示厅办事处仍在计划中；拨款已取消 |
| The 2024 report planned to introduce the Digital Humidifier Monitoring Sensor.2024 年报计划推出 Digital Humidifier Monitoring Sensor。 | The 2025 report says UWHM launched no new products during the year and was still preparing to introduce the sensor.2025 年报表示，UWHM 年内没有推出新产品，仍在准备推出该传感器。 Source: annual report 2024, page 21; annual report 2025, page 21.出处：2024 年年报第 21 页；2025 年年报第 21 页。 | Still planned仍在计划中 |
| The 2023 report planned to enter nursing home management and ambulance services.2023 年报计划进入护理院管理及救护车服务领域。 | The 2025 report describes the UMC Healthcare Centre and the incorporation of Rescue Medic. The medical services launch on 15 August 2025 included the healthcare centre, ambulance services and learning centre.2025 年报介绍了 UMC Healthcare Centre 及 Rescue Medic 的成立。2025 年 8 月 15 日的医疗服务推介包括护理中心、救护车服务及学习中心。 Source: annual report 2023, page 11; annual report 2025, pages 12, 13, 15, 18.出处：2023 年年报第 11 页；2025 年年报第 12、13、15、18 页。 | Services launched服务已推出 |
| The 2023 report targeted December 2023 for starting to use solar panels.2023 年报把开始使用太阳能板的目标定于 2023 年 12 月。 | The 2024 report says use began in December 2023 after installation in October.2024 年报表示，太阳能板于 10 月安装后，在 2023 年 12 月开始使用。 Source: annual report 2023, page 14; annual report 2024, page 15.出处：2023 年年报第 14 页；2024 年年报第 15 页。 | Started when stated按所述时间开始使用 |
What the reports leave open年报留下待看的事
- The latest report leaves machinery, systems and cleanroom spending unfinished: 8.49% of that IPO allocation was used, with the utilisation period extended to 4 December 2025. Contracted capital commitments stood at RM6.9 million.最新年报显示，机械、系统及洁净室支出尚未完成：相关首次公开募股拨款已使用 8.49%，使用期限延至 2025 年 12 月 4 日。已签约资本承诺为 RM6.9 million。
Source: annual report 2025, pages 85, 127.出处：2025 年年报第 85、127 页。
- Monthly humidifier capacity was reported at 433,000 bottles. The earlier target was 600,000 by December 2024; the latest report gives no new date for reaching it.所报湿化瓶月产能为 433,000 瓶。此前目标是在 2024 年 12 月达到 600,000 瓶；最新年报没有给出达到该目标的新日期。
Source: annual report 2024, page 14; annual report 2025, page 14.出处：2024 年年报第 14 页；2025 年年报第 14 页。
- The Digital Humidifier Monitoring Sensor remains a planned introduction. The latest report gives no launch date.Digital Humidifier Monitoring Sensor 仍属计划推出的产品。最新年报没有给出推出日期。
Source: annual report 2025, page 21.出处：2025 年年报第 21 页。
- Ateria was still discussing distributorship rights for blood transfusion consumables and equipment. Patho's CYTOWIZ collaboration also included further discussions on an exclusive arrangement.Ateria 仍在洽谈输血耗材及设备的分销权。Patho 与 CYTOWIZ 的合作也包括进一步讨论独家安排。
Source: annual report 2025, page 22.出处：2025 年年报第 22 页。
Facts as printed in the company's annual reports, with the page of each; no rating and no advice. Built 2026-10-28.内容为公司年报所印的事实，并注明页码；不评级，不构成投资建议。生成日期 2026-10-28。